Abdullah a. alangari
P.O. Box 89805, Riyadh 11629, saudi arabiaMobile 0506287276 – email:
Education
5/2007 – 12/2007
6/2008 – 8/2008 / § Visiting Scholar
Division of Infection, Inflammation, and Repair
School of Medicine, University of Southampton
Southampton, UK
7/2000 – 6/2003 / § Fellow in Allergy & Immunology
Children’s Hospital
Harvard Medical School
Boston, Massachusetts, USA
6/1997 – 6/2000 / § Pediatric Resident
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts, USA
10/1994 – 4/1997 / § Pediatric Resident
King Fahad National Guard Hospital
Department of Pediatrics
Riyadh, Saudi Arabia
7/1993 – 7/1994 / § Intern
King Khalid University Hospital
King Saud University, College of Medicine
Riyadh, Saudi Arabia
9/1987 – 6/1993 / § Medical Student
King Saud University
College of Medicine
Riyadh, Saudi Arabia
Certifications
8/2003 / § American Board of Allergy and Immunolgoy
10/2000 / § American Board of Pediatrics
12/1998 / § USMLE, Step 3
8/1995 / § MRCP (UK) Part 1 – Pediatrics
9/1995 / § ECFMG
3/1995 / § USMLE, Step 2
9/1994 / § USMLE , Step 1
7/1993 / § MBBS with Honors
Licensure
28/7/1999 / § The commonwealth of Massachusetts – Board of Registration in Medicine (USA). Certificate No. 160993
13/1/2007 / § Saudi Commision for Health Specialties. Consultant Pediatrician. Consultant Allergist, and Immunologist. Registration ID No. 07-R-M-1150
work experience
1/2015 - present / § Professor of Pediatrics. College of Medicine, King Saud Univeristy
10/2010 – 12/2014 / § Associate Professor of Pediatrics. College of Medicine, King Saud University.
2005 – 9/2010 / § Assistant Professor of Pediatrics. College of Medicine, King Saud University.
2004 – present / § Consultant Pediatrician, Allergist, and Immunologis. King Khalid University Hospital.
5/2005 – 11/2008
10/2009 – 8/2013
9/2016 - present / § Head of the Allergy and Immunology Unit at the department of Pediatrics, King Khalid University Hospital.
11/2008 – 9/2009 / § Consultant Pediatrician, Allergist, and Immunologist. King Fahad Medical city (KFMC). [Secondment]
§ Co-chairman of the medical students committee (KFMC).
4/2010 – 7/2013 / § Interns supervisor. Faculty of Medicine at King Fahad Mdical City, KSAU-HS. [part time]
Committees
§ Participated in interviews of applicants for health specialties colleges, King Saud University.
May, 2016 / § Reviewer and member of the reviewing committee for King Faisal international Prize in Medicine 2017
2009 – 2013
2014 - present
/ § Member of the Pediatrics Allergy and Immunology Fellowship Program Supervising committee at the Saudi Commission for Health Specialties.
2009 – 2013 / § Member of the mortality and morbidity committee, Dep. Of Pediatrics, College of Medicine, King Saud University.
8/2005 – 6/2008 / § Chairman of the Undergraduate Teaching Program Committee, Dept. of Pediatrics, College of Medicine, King Saud University.
8/2005 – 8/2007 / § Academic Mentor of the 5th year medical students, College of Medicine, King Saud Universiy.
Academies and societies affiliation
§ Fellow of the Americal Academy of Allergy and Immunology
§ Member of the Saudi Allergy and Asthma Society
§ Fellow of the American Academy of Pediatrics
§ Member of the Saudi Pediatrics Association
Reviewer for the following journals
§ Clinical Immunology. The official journal of the clinical immunology society (USA)
§ Saudi Medical Journal
§ Annals of Saudi Medicine
§ Medical Education
§ Respiratory Research
Publications and abstracts
§ Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG; Greater Middle East Variome Consortium., Alkuraya FS, Casanova JL, Gleeson JG. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat Genet. 2016 Sep;48(9):1071-6.
§ Shaheen R, Patel N, Shamseldin H, Alzahrani F, Al-Yamany R, ALMoisheer A, Ewida N, Anazi S, Alnemer M, Elsheikh M, Alfaleh K, Alshammari M, Alhashem A, Alangari AA, Salih MA, Kircher M, Daza RM, Ibrahim N, Wakil SM, Alaqeel A, Altowaijri I, Shendure J, Al-Habib A, Faqieh E, Alkuraya FS. Accelerating matchmaking of novel dysmorphology syndromes through clinical and genomic characterization of a large cohort. Genet Med. 2016 Jul;18(7):686-95.
§ Charbonnier L-M, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, Massaad MJ, Garcia-Lloret M, Hanna-Wakim R, Dbaibo G, Alangari AA, Alsultan A, Al-Zahrani D, Geha RS, Chatila TA. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol. 2015;135:217-227
§ Alangari AA, Riaz M, Mahjoub MO, Malhis N, Al-Tamimi S, Al-Modaihsh A. The Effect of Sand Stroms on Acute Asthma in Riyadh, Saudi Arabia. Ann Thorac Med.2015;10(1):29-33
§ Alangari AA. Characteristics of Patients Presenting to the Emergency Department with Anaphylaxis in Riyadh, Saudi Arabia. Journal of Taibah University Medical Sciences.2014;9(4):318-321
§ Alangari AA. Corticosteroids in the Treatment of Acute Asthma. Anna Thorac Med.2014;9(4):187-192
§ Al-Dosary K, Al-Qahtani A, Alangari AA. Anaphylaxis to Lidocain with Tolerance to Articain in a 12 years old girl. Saudi Pharmaceutical Journal.2014;22:280-282
§ Alangari AA, Malhis N, Mubashir M, Al-Ghamedi N, Al-Tannir M, Riaz M, Umetsu DT, Al-Tamimi S. Budesonide Nebulization Added to Systemic Prednisolone in The Treatment of Acute Asthma in Children: Doube-Blind, Randomized, Controlled Trial. Chest.2014; 145(4):772-778
§ Alangari AA. Normocomplementemic Urticarial Vasculitis in a Boy and his Response to Treatment. Curr Pediatr Res.2014;18(1):8-10
§ Alfares FA, Raddaui EM, El-Mozan MI, Alangari AA. Menetrier’s disease in a Saudi child. Saudi Med J.2013;34(11):1192-4
§ Alangari AA, Alsultan A, Osman M, Anazi S, Alkuraya F. A Novel Homozygous Mutation in G6PC3 Presenting as Cyclic Neutropenia and Severe Congenital Neutropenia in the Same Family. J Clin Immunol.2013;33(8):1403-6
§ Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, et al. Inherited IL-12p40 Deficiency: Genetic, Immunologic, and Clinical Features of 49 Patients From 30 Kindreds. Medicine (Baltimore). 2013;92:109-122 [Erratum. Medicine (Baltimore). 2013;92:190]
§ Book Chapter: Alangari AA. The Use of Glucocorticoids in the Treatment of Acute Asthma Exacerbations. In: Qian, X, eds. Glucocorticoids-new recognistion of our familiar friend. In tech; 2012.501-522 p.
§ Al-Khayyat A, Al-Anazi M, Warsy A, Vazquez-Tello A, Alamri AM, Halwani R,AlangariAA, Al-Frayh A, Hamid Q, Al-Muhsen S. T1 and T2 ADAM33 single nucleotide polymorphisms and the risk of childhood asthma in a Saudi Arabian population: a pilot study. Ann Saudi Med.2012;32:479-486
§ Alangari AA, Alsultan A, Adly N, Massad M, Kiani IS, Aljebreen A, et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol. 2012;130:481-8
§ Shaffiq A, Haitchi H-M, Pang Y, Alangari AA, Jones M, Marshall B, Howarth P, O’Reilly K, Davies D. A Disintegrin And Metalloprotease (ADAM)33 Protein in Patients with Sarcoidosis. Respirology. 2012;17:342-349
§ Sancho-Shimizu V, de Diego RP, Lorenzo L, Halwani R, Alangari AA, et al. Herpes simplex encephalitis in patients with autosomal recessive and dominant TRIF deficiency. J Clin Invest. 2011;121:4889-4902
§ Alangari AA, Al-Zamil F, Al-Mazrou A, Al-Muhsen S, Boisson-Dupuis S, Awadallah S, Kambal A, Casanova J-L. Treatment of disseminated mycobacterial infectionwith high dose IFN-g in a patient with IL-12Rb1 deficiency. Clin Dev Immunol.2011, doi:10.1155/2011/691956
§ Alangari AA. Genomic and non-genomic actions of glucocorticoids in asthma. Ann Thorac Med. 2010;5:133-39
§ de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rb1 deficiency: a survey of 140 patients from 30 countries. Medicine (Baltimore). 2010;89:381-402
§ Cote M, Menager M, Burgess A, Mahlaoui N, Picard C, Schaffner C, Al-Manjomi F, Al-Harbi M, Alangari A, et al. Munc18-2 deficiency casuses familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119:3765-73
§ Alangari AA, Al-Harbi A, Al-Ghonaium A, Santisteban I, Hershfield M. Purine nucleoside phosphorylase deficiency in Two Unrelated Saudi Patients. Ann Saudi Med. 2009;29:309-312
§ Alangari AA. Students’ perception of the pediatrics course in a Saudi Medical School. J T U Med Sc. 2008;3(2):135-139
§ Alangari AA, Abutaleb M, Albarraq A, Al-Dhowailie. Immediate adverse reactions of intravenous immunoglobulins. Cur Pediatr Res. 2008;12:31-34
§ Alangari AA, Abutaleb M, Albarraq A, Al-Dhowailie. Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia. Saudi Med J. 2008;27:477-481
§ Alangari AA, Lau LC, Zhou XY, Mochizuki A, Salagean EM, Salib RJ, Howarth PH, Walls AF. Differential Release and Clearance of Mast Cell and Basophil Mediators in the Uper Airways of Patients with Allergic Rhinitis. J Allergy Clin Immunol. 2008;121(2):S152
§ Zhou XY, Lau LC, Tabares CM, Alangari AA, Summers C, Pumphrey RS, Wild G, Escribano L, Walls AF. Mast cell proteases as new clinical markers of anaphylaxis and mastocytosis. Abstract presented at the MRC meeting in Edinburgh, UK. September, 2007
§ Alangari AA, Abobaker A, Kanegane H, Miyawaki T. X-linked Lymphoproliferative Disease Associated with Hypogammaglobulinemia and Growth Hormone Deficiency. Eur J Pediatr. 2006;165:-165-167
§ Alangari AA, Twarog FJ, Shih M-C, Schneider LC. Clinical Features and Anaphylaxis in Children with Cold Urticaria. Pediatrics. 2004;113:e313-e317
§ Leung DYM, Sampson HA, Yunginger A, Burks AW, Schneider LC, Wortel CH, et al. Effect of Anti-IgE Therapy in Patients with Peanut Allergy. N Engl J Med. 2003; 13; 348:986-993 (among the TNX-901 peanut allergy study group)
§ Alangari A, Schneider L, Geha R, Nurko S, Bonilla F. Primary Sclerosing Cholangitis in a Patient with Possible Hyper-IgE Syndrome. J Allergy Clin Immunol. 2002; 109(1):S192
RESEARCH GRANTS AWARDED
2013 / § Grant source: King Abdulaziz City for Science and Technology.
Project number: 12-NAN2537-02. Title: Design, development and evaluation of a nano- transdermal (needle-free) allergy test for diagnosis of type-1 hypersensitivity. (Co-investigator)
[Grant was awarded, but the project was not carried out]
2012 / § Grant source: Deanship for Scientific Research, King Saud University.
Project number: RGP-VPP-190. Title: The immunomodulatory properties of honey. (Primary Investigator)
2010 / § Grant source: King Abdulaziz City for Science and Technology.
Project number: 08-MED520-02. Title: The use of inhaled corticosteroids in the treatment of acute asthma in children in the emergency room. (Primary investigator)
2008 / § Grant source: King Abdulaziz City for Science and Technology – Summer grant.
Project title: The Role of ADAM33 in Asthma. (Co-investigator)
2007 / § Grant source: British Council.
Project Title: Investigation of the Potential for Differential Activation of Mast Cells and Basophils using new Assays for Biochemical Markers.(Co-investigator)
2006 / § Grant source: Research Center, College of Medicine, King Saud University.
Project Number: 05-519. Title: The role of IFN-g in the treatment of disseminated mycobacterial infection in patients with IL-12Rb1 deficiency.(Primary investigator)
2005 / § Grant source: King Abdulaziz City for Science and Technology.
Project Number: 10-26-420. Title: Genotyping and phenotyping of Saudi patients with chronic granulomatous disease. (Co-investigator)
pERSONAL iNFORMATION
Name / Abdullah A. Alangari
Date of Birth / September 2nd, 1970
Marital Status / Married. Has four children
Nationality / Saudi
Languages / Arabic and English